Metropolitan Life Insurance Company (MetLife)’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-5,276
| Closed | -$19.2K | – | 1416 |
|
|
2024
Q1 | $19.2K | Buy |
5,276
+1,338
| +34% | +$4.87K | ﹤0.01% | 1882 |
|
|
2023
Q4 | $5.95K | Sell |
3,938
-4,860
| -55% | -$7.34K | ﹤0.01% | 2271 |
|
|
2023
Q3 | $11.8K | Buy |
8,798
+1,842
| +26% | +$2.47K | ﹤0.01% | 2144 |
|
|
2023
Q2 | $12.5K | Hold |
6,956
| – | – | ﹤0.01% | 2179 |
|
|
2023
Q1 | $11.5K | Sell |
6,956
-569
| -8% | -$945 | ﹤0.01% | 2103 |
|
|
2022
Q4 | $14.4K | Hold |
7,525
| – | – | ﹤0.01% | 2150 |
|
|
2022
Q3 | $16.9K | Hold |
7,525
| – | – | ﹤0.01% | 2104 |
|
|
2022
Q2 | $24.4K | Sell |
7,525
-3,474
| -32% | -$11.3K | ﹤0.01% | 1945 |
|
|
2022
Q1 | $57.9K | Sell |
10,999
-31,743
| -74% | -$167K | ﹤0.01% | 1518 |
|
|
2021
Q4 | $363K | Buy |
42,742
+23,410
| +121% | +$199K | ﹤0.01% | 1624 |
|
|
2021
Q3 | $192K | Buy |
19,332
+6,321
| +49% | +$62.8K | ﹤0.01% | 2109 |
|
|
2021
Q2 | $121K | Buy |
+13,011
| New | +$121K | ﹤0.01% | 2494 |
|